Erste Asset Management’s Roivant Sciences ROIV Stock Holding History

Erste Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29M	Buy	834,000 +620,000	+290%	+$18.3M	0.23%	106
2026 Q1	$5.65M	Hold	214,000	–	–	0.05%	257
2025 Q4	$4.64M	Hold	214,000	–	–	0.04%	281
2025 Q3	$3.23M	Hold	214,000	–	–	0.03%	301
2025 Q2	$2.44M	Hold	214,000	–	–	0.02%	372
2025 Q1	$2.22M	Hold	214,000	–	–	0.03%	294
2024 Q4	$2.53M	Hold	214,000	–	–	0.03%	296
2024 Q3	$2.46M	Sell	214,000 -32,000	-13%	-$364K	0.03%	295
2024 Q2	$2.6M	Hold	246,000	–	–	0.03%	286
2024 Q1	$2.67M	Hold	246,000	–	–	0.04%	280
2023 Q4	$2.8M	Buy	246,000 +64,000	+35%	+$624K	0.04%	265
2023 Q3	$2.28M	Buy	+182,000	New	+$2.06M	0.04%	266

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Erste Asset Management's ROIV Position: Q2 2026 in Review

Erste Asset Management increased its Roivant Sciences (ROIV) stake by 290% in Q2 2026, buying an estimated $18.3M and bringing the position to 834,000 shares worth $29M. The position accounts for 0.23% of the portfolio, ranked #106.

Erste Asset Management first reported a position in ROIV in Q3 2023 and has held it in 12 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Erste Asset Management held 834,000 shares of Roivant Sciences worth $29M as of Q2 2026.
Erste Asset Management bought 620,000 Roivant Sciences shares in Q2 2026, an estimated $18.3M.
Roivant Sciences made up 0.23% of Erste Asset Management's portfolio in Q2 2026, its #106 holding.
Erste Asset Management first reported a position in Roivant Sciences in Q3 2023 and has held it in 12 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.